Biological activities of resveratrol and its analogs

Drugs of the Future

Volumn 27, Issue 10, 2002, Pages 949-959

  Wolter, Freya ^a   Stein, Jürgen ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ARACHIDONIC ACID; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450; ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHYTOALEXIN; PROSTAGLANDIN SYNTHASE; RESVERATROL;

ALLERGY; ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; ARACHIDONIC ACID METABOLISM; CANCER INHIBITION; CANCER THERAPY; CELL CYCLE; CELL DIFFERENTIATION; DRUG MECHANISM; DRUG METABOLISM; GRAPE; HEART PROTECTION; HORMONE ACTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; NEOVASCULARIZATION (PATHOLOGY); NEUROPROTECTION; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0036820498     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2002.027.10.856987     Document Type: Review

References (105)

1. Soleas, G.J., Diamandis, E.P., Goldberg, D.M. Resveratrol: A molecule whose time has come? And gone? Clin Biochem 1997, 30: 91-113.
2. Burns, J., Yokota, T., Ashihara, H., Lean, M.E.J., Crozier, A. Plant foods and herbal sources of resveratrol. J Agric Food Chem 2002, 50: 3337-40.
3. Langcake, P., Pryce, R.J. The production of resveratrol by vitis vinifera and other members of the vitaceae as a response to infection or injury. Physiol Plant Pathol 1976, 9: 77-86.
4. Romero-Pérez, A.I., Ibern-Gómez, M., Lamuela-Raventós, R.M., de la Torre-Boronat, M.C. Piceid, the major resveratrol derivative in grape juices. J Agric Food Chem 1999, 47: 1533-6.
5. Siemann, E.H., Creasy, L.L. Concentration of phytoalexin resveratrol in wine. Am J Enol Vitic 1992, 43: 49-52.
6. Sanders, T.H., McMichael, R.W. Jr., Hendrix, K.W. Occurrence of resveratrol in edible peanuts. J Agric Food Chem 2000, 48: 1243-6.
7. Ibern-Gómez, M., Roig-Pérez, S., Lamuela-Raventós, R.M., de la Torre-Boronat, M.C. Resveratrol and piceid levels in natural and blended peanut butters. J Agric Food Chem 2000, 48: 6352-4.
8. Pace-Asciak, C.R., Hahn, S., Diamandis, E.P., Soleas, G., Goldberg, D.M. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease. Clin Chim Acta 1995, 235: 207-19.
9. Belguendouz, L., Fremont, L., Gozzelino, M.T. Interaction of trans-resveratrol with plasma lipoproteins. Biochem Pharmacol 1998, 55: 811-6.
10. Chen, C.K., Pace-Asciak, C.R. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen Pharmacol 1996, 27: 363-6.
11. Jang, M., Cai, L., Udeani, G.O. et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275: 218-20.
12. Bishop, A.C., Moore, D., Scanlan, T.S., Shokat, K.M. Screening a hydroxystilbene library for selective inhibition of the B cell antigen receptor kinase cascade. Tetrahedron 1997, 53: 11995-2004.
13. Juan, M.E., Vinardell, M.P., Planas, J.M. The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J Nutr 2002, 132: 257-60.
14. Andlauer, W., Kolb, J., Siebert, K., Furst, P. Assessment of resveratrol bioavailability in the perfused small intestine of the rat. Drugs Exp Clin Res 2000, 26: 47-55.
15. Kuhnle, G., Spencer, J.P., Chowrimootoo, G. et al. Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Biochem Biophys Res Commun 2000, 272: 212-7.
16. Aumont, V., Krisa, S., Battaglia, E. et al. Regioselective and stereospecific glucuronidation of trans- and cis-resveratrol in human. Arch Biochem Biophys 2001, 393: 281-9.
17. de Santi, C., Pietrabissa, A., Spisni, R., Mosca, F., Pacifici, G.M. Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids. Xenobiotica 2000, 30: 857-66.
18. de Santi, C., Pietrabissa, A., Spisni, R., Mosca, F., Pacifici, G.M. Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum. Xenobiotica 2000, 30: 609-17.
19. Bertelli, A., Bertelli, A.A., Gozzini, A., Giovannini, L. Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp Clin Res 1998, 24: 133-8.
20. Bertelli, A.A., Giovannini, L., Stradi, R. et al. Evaluation of kinetic parameters of natural phytoalexin in resveratrol resveratrol orally administered in wine to rats. Drugs Exp Clin Res 1998, 24: 51-5.
21. Marier, J.F., Vachon, P., Gritsas, A. et al. Metabolism and disposition of resveratrol in rats: Extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther 2002, 302: 369-73.
22. Soleas, G.J., Yan, J., Goldberg, D.M. Measurement of transresveratrol, (+)-catechin, and quercetin in rat and human blood and urine by gas chromatography with mass selective detection. Methods Enzymol 2001, 335: 130-45.
23. Fremont, L. Biological effects of resveratrol. Life Sci 2000, 66: 663-73.
24. Brakenhielm, E., Cao, R., Cao, Y. Suppression of angiogenesis, tumor growth, and wound heating by resveratrol, a natural compound in red wine and grapes. FASEB J 2001, 15: 1798-800.
25. Carbo, N., Costelli, P., Baccino, F.M., Lopez-Soriano, F.J., Argiles, J.M. Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem Biophys Res Commun 1999, 254: 739-43.
26. Hecht, S.S., Kenney, P.M., Wang, M. et al. Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumori-genesis in A/J mice. Cancer Lett 1999, 137: 123-30.
27. Tessitore, L., Davit, A., Sarotto, I., Caderni, G. Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and P21(CIP) expression. Carcinogenesis 2000, 21: 1619-22.
28. Schneider, Y., Duranton, B., Gosse, F. et al. Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr Cancer 2001, 39: 102-7.
29. Gao, X., Xu, Y.X., Divine, G. et al. Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes. J Nutr 2002, 132: 2076-81.
30. Kimura, Y., Okuda, H. Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr 2001, 131: 1844-9.
31. Kimura, Y., Okuda, H. Effects of naturally occurring stilbene glucosides from medicinal plants and wine, on tumour growth and lung metastasis in Lewis lung carcinoma-bearing mice. J Pharm Pharmacol 2000, 52: 1287-95.
32. Rimando, A.M., Cuendet, M., Desmarchelier, C. et al. Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol. J Agric Food Chem 2002, 50: 3453-7.
33. 2 phase transition. Biochem Biophys Res Commun 1998, 250: 53-8.
34. Wolter, F., Stein, J. Resveratrol enhances the differentiation induced by butyrate in Caco-2 colon cancer cells. J Nutr 2002, 132: 2082-6.
35. Mahyar-Roemer, M., Katsen, A., Mestres, P., Roemer, K. Resveratrol induces colon tumor cell apoptosis independently of p53 and preceded by epithelial differentiation, mitochondrial proliferation and membrane potential collapse. Int J Cancer 2001, 94: 615-22.
36. Johnson, J.L., Maddipati, K.R. Paradoxical effects of resveratrol on the two prostaglandin H synthases. Prostaglandins Other Lipid Mediat 1998, 56: 131-43.
37. Subbaramaiah, K., Chung, W.J., Michaluart, P. et al. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 1998, 273: 21875-82.
38. Mutoh, M., Takahashi, M., Fukuda, K. et al. Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcintype structure. Carcinogenesis 2000, 21: 959-63.
39. Martinez, J., Moreno, J.J. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol 2000, 59: 865-70.
40. MacCarrone, M., Lorenzon, T., Guerrieri, P., Agro, A.F. Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur J Biochem 1999, 265: 27-34.
41. Moreno, J.J. Resveratrol modulates arachidonic acid release, prostaglandin synthesis, and 3T6 fibroblast growth. J Pharmacol Exp Ther 2000, 294: 333-8.
42. Manna, S.K., Mukhopadhyay, A., Aggarwal, B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κB, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 2000, 164: 6509-19.
43. Holmes-McNary, M., Baldwin, A.S. Jr. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IκB kinase. Cancer Res 2000, 60: 3477-83.
44. Tsai, S.H., Lin-Shiau, S.Y., Lin, J.K. Suppression of nitric oxide synthase and the down-regulation of the activation of NFκB in macrophages by resveratrol. Br J Pharmacol 1999, 126: 673-80.
45. Godichaud, S., Krisa, S., Couronne, B. et al. Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapevine-derived polyphenol. Hepatology 2000, 31: 922-31.
46. Yu, R., Hebbar, V., Kim, D.W. et al. Resveratrol inhibits phorbol ester and UV-induced activator protein 1 activation by interfering with mitogen-activated protein kinase pathways. Mol Pharmacol 2001, 60: 217-24.
47. Miloso, M., Bertelli, A.A., Nicolini, G., Tredici, G. Resveratrol-induced activation of the mitogen-activated protein kinases, ERK1 and ERK2, in human neuroblastoma SH-SY5Y cells. Neurosci Lett 1999, 264: 141-4.
48. El Mowafy, A.M., White, R.E. Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: Reversal of endothelin-1 stimulatory effects. FEBS Lett 1999, 451: 63-7.
49. Garcia-Garcia, J., Micol, V., de Godos, A., Gomez-Fernandez, J.C. The cancer chemopreventive agent resveratrol is incorporated into model membranes and inhibits protein kinase C α activity. Arch Biochem Biophys 1999, 372: 382-8.
50. Stewart, J.R., Christman, K.L., O'Brian, C.A. Effects of resveratrol on the autophosphorylation of phorbol ester-responsive protein kinases: Inhibition of protein kinase D but not protein kinase C isozyme autophosphorylation. Biochem Pharmacol 2000, 60: 1355-9.
51. Geahlen, R.L., McLaughlin, J.L. Piceatannol (3,4,3′,5′-tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitor. Biochem Biophys Res Commun 1989, 165: 241-5.
52. Palmieri, L., Mameli, M., Ronca, G. Effect of resveratrol and some other natural compounds on tyrosine kinase activity and on cytolysis. Drugs Exp Clin Res 1999, 25: 79-85.
53. 3 signaling in platelets. Blood 1999, 93: 2645-52.
54. Fontecave, M., Lepoivre, M., Elleingand, E., Gerez, C., Guittet, O. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett 1998, 421: 277-9.
55. Hsieh, T.C., Burfeind, P., Laud, K. et al. Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials. Int J Oncol 1999, 15: 245-52.
56. Bernhard, D., Tinhofer, I., Tonko, M. et al. Resveratrol causes arrest in the S-phase prior to fas-independent apoptosis in CEM-C7H2 acute leukemia cells. Cell Death Differ 2000, 7: 834-42.
57. 2. Cancer Res 1999, 59: 2596-601.
58. Joe, A.K., Liu, H., Suzui, M. et al. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res 2002, 8: 893-903.
59. Kuwajerwala, N., Cifuentes, E., Gautam, S. et al. Resveratrol induces prostate cancer cell entry into S phase and inhibits DNA synthesis. Cancer Res 2002, 62: 2488-92.
60. 2 phases of the cell cycle in U937 cells. Cancer Lett 2001, 163: 43-9.
61. Schneider, Y., Vincent, F., Duranton, B. et al. Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Lett 2000, 158: 85-91.
62. Wolter, F., Akoglu, B., Clausnitzer, A., Stein, J. Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J Nutr 2001, 131: 2197-203.
63. 1-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res 2001, 7: 1466-73.
64. Adhami, V.M., Afaq, F., Ahmad, N. Involvement of the retinoblastoma (PRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells. Biochem Biophys Res Commun 2001, 288: 579-85.
65. Hsieh, T.C., Wu, J.M. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp Cell Res 1999, 249: 109-15.
66. Stivala, L.A., Savio, M., Carafoli, F. et al. Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J Biol Chem 2001, 276: 22586-94.
67. Wolter, F., Clausnitzer, A., Akoglu, B., Stein, J. Piceatannol, a natural analog of resveratrol, inhibits progression through the S phase of the cell cycle in colorectal cancer cell lines. J Nutr 2002, 132: 298-302.
68. Mitchell, S.H., Zhu, W., Young, C.Y. Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Cancer Res 1999, 59: 5892-5.
69. Ferry-Dumazet, H., Garnier, O., Mamani-Matsuda, M. et al. Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis 2002, 23: 1327-33.
70. Surh, Y.J., Hurh, Y.J., Kang, J.Y. et al. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett 1999, 140: 1-10.
71. Tinhofer, I., Bernhard, D., Senfter, M. et al. Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2. FASEB J 2001, 15: 1613-5.
72. Dörrie, J., Gerauer, H., Wachter, Y., Zunino, S.J. Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Res 2001, 61: 4731-9.
73. Clement, M.V., Hirpara, J.L., Chawdhury, S.H., Pervaiz, S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 1998, 92: 996-1002.
74. Tsan, M.F., White, J.E., Maheshwari, J.G., Bremner, T.A., Sacco, J. Resveratrol induces fas signalling-independent apoptosis in THP-1 human monocytic leukaemia cells. Br J Haematol 2000, 109: 405-12.
75. Park, J.W., Choi, Y.J., Suh, S.I. et al. Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity. Carcinogenesis 2001, 22: 1633-9.
76. Huang, C., Ma, W.Y., Goranson, A., Dong, Z. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 1999, 20: 237-42.
77. Shih, A., Davis, F.B., Lin, H.Y., Davis, P.J. Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism. J Clin Endocrinol Metab 2002, 87: 1223-32.
78. Lin, H.Y., Shih, A., Davis, F.B. et al. Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line. J Urol 2002, 168: 748-55.
79. Rodrigue, C.M., Arous, N., Bachir, D. et al. Resveratrol, a natural dietary phytoalexin, possesses similar properties to hydroxyurea towards erythroid differentiation. Br J Haematol 2001, 113: 500-7.
80. She, Q.B., Bode, A.M., Ma, W.Y., Chen, N.Y., Dong, Z. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res 2001, 61: 1604-10.
81. Baek, S.J., Wilson, L.C., Eling, T.E. Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53. Carcinogenesis 2002, 23: 425-34.
82. Lu, J., Ho, C.H., Ghai, G., Chen, K.Y. Resveratrol analog, 3,4,5,4′-tetrahydroxystilbene, differentially induces pro-apoptotic p53/Bax gene expression and inhibits the growth of transformed cells but not their normal counterparts. Carcinogenesis 2001, 22: 321-8.
83. Igura, K., Ohta, T., Kuroda, Y., Kaji, K. Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett 2001, 171: 11-6.
84. Kozuki, Y., Miura, Y., Yagasaki, K. Resveratrol suppresses hepatoma cell invasion independently of its anti-proliferative action. Cancer Lett 2001, 167: 151-6.
85. Caltagirone, S., Rossi, C., Poggi, A. et al. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer 2000, 87: 595-600.
86. Demeule, M., Brossard, M., Page, M., Gingras, D., Beliveau, R. Matrix metalloproteinase inhibition by green tea catechins. Biochim Biophys Acta 2000, 1478: 51-60.
87. Gehm, B.D., McAndrews, J.M., Chien, P.Y., Jameson, J.L. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 1997, 94: 14138-43.
88. Lu, R., Serrero, G. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J Cell Physiol 1999, 179: 297-304.
89. Ashby, J., Tinwell, H., Pennie, W. et al. Partial and weak oestrogenicity of the red wine constituent resveratrol: Consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effects. J Appl Toxicol 1999, 19: 39-45.
90. Bowers, J.L., Tyulmenkov, V.V., Jernigan, S.C., Klinge, C.M. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors α and β. Endocrinology 2000, 141: 3657-67.
91. Cheong, H., Ryu, S.Y., Kim, K.M. Anti-allergic action of resveratrol and related hydroxystilbenes. Planta Med 1999, 65: 266-8.
92. Miura, K., Lavens-Phillips, S., MacGlashan, D.W. Jr. Piceatannol is an effective inhibitor of IgE-mediated secretion from human basophils but is neither selective for this receptor nor acts on syk kinase at concentrations where mediator release inhibition occurs. Clin Exp Allergy 2001, 31: 1732-9.
93. Virgili, M., Contestabile, A. Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats. Neurosci Lett 2000, 281: 123-6.
94. Bastianetto, S., Zheng, W.H., Quirion, R. Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br J Pharmacol 2000, 131: 711-20.
95. Miura, T., Muraoka, S., Ikeda, N., Watanabe, M., Fujimoto, Y. Antioxidative and prooxidative action of stilbene derivatives. Pharmacol Toxicol 2000, 86: 203-8.
96. Olas, B., Wachowicz, B. Resveratrol and vitamin C as antioxidants in blood platelets. Thromb Res 2002, 106: 143.
97. Heredia, A., Davis, C., Redfield, R. Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol. J Acquir Immune Defic Syndr 2000, 25: 246-55.
98. Frötschl, R., Chichmanov, L., Kleeberg, U. et al. Prediction of aryl hydrocarbon receptor-mediated enzyme induction of drugs and chemicals by mRNA quantification. Chem Res Toxicol 1998, 11: 1447-52.
99. Chun, Y.J., Kim, M.Y., Guengerich, F.P. Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem Biophys Res Commun 1999, 262: 20-4.
100. Ciolino, H.P., Yeh, G.C. Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol Pharmacol 1999, 56: 760-7.
101. Chang, T.K., Lee, W.B., Ko, H.H. Trans-resveratrol modulates the catalytic activity and mRNA expression of the procarcinogen-activating human cytochrome P450 1B1. Can J Physiol Pharmacol 2000, 78: 874-81.
102. Potter, G.A., Patterson, L.H., Wanogho, E. et al. The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br J Cancer 2002, 86: 774-8.
103. Casper, R.F., Quesne, M., Rogers, I.M. et al. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: Implications for prevention of dioxin toxicity. Mol Pharmacol 1999, 56: 784-90.
104. Kawada, N., Seki, S., Inoue, M., Kuroki, T. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology 1998, 27: 1265-74.
105. Zoberi, I., Bradbury, C.M., Curry, H.A. et al. Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines. Cancer Lett 2002, 175: 165-73.